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As we are witnessing major technological and inform-
atics progress on a daily basis, the emphasis on transla-
tional approach in medical research has become not
only clearly needed but also practically achievable. In
addition, very closely linked fields such as Anesthesia,
Pain Medicine and Critical Care may benefit mostly of
the development and consolidation of translational
medicine. From its “bench to bedside” and beyond, in
the community, translational medicine touches the real
goal of research which is to understand in order to cor-
rectly and adequately apply. Changes in the way we
provide patients’ medical care require rigorous process
and thorough analytical work so to reach the stage of
implementing policies and strategies on the wider
population.
Acute Respiratory Distress Syndrome (ARDS) is an
example of how focus on translational research may
lead to a better understanding of the disease. Defining
ARDS continues to remain a challenge but it is also an
essential step before including patients in ARDS related
clinical trials. The clinical definition of ARDS and its
diagnostic criteria have been subject to few revisions since
the disease was initially described, in 1967, by Ashbaugh
DG et al [1]. In 1994 the American European Consensus
Criteria were used to redefine the disease [2]. However,
ARDS was more recently reviewed again by the definition
of the Berlin Consensus [3,4]. Despite of all these at-
tempts, it remains true, however, that up to 50% of pa-
tients included in ARDS-related randomized trials may
well be false positives. This would explain why over 200
randomized clinical trials had failed to identify consistent
conclusions on therapeutic interventions as explained in
the editorial of S. Fröhlich et al. who conclude that with-
out specific biomarker, it is unlikely to make real progress
in tackling this deadly disease [5]. On the other hand
understanding and treating pain syndromes, such as
Complex Regional Pain Syndrome (CRPS), still long
way far from done. CRPS diagnosis relies mainly onCorrespondence: yalmakadma@sidra.org
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unless otherwise stated.bedside criteria and subjective findings and descriptions
by both the patient and the physician [6,7]. Whether we
consider “sensory sympathetic coupling”, “cortical re-
organization” related to CRPS, underlying local mecha-
nisms and genes translation in familial “CRPS” cases
remain all to apprehend. Findings of Functional MRI
are an example of how translational approach may well
be of great value. Focused translational research may
thus help us identifying biomarker(s) for the disease so
that we may be able to start its management earlier
and perhaps have less disabling outcome.
The concept of “Translational Medicine” represents a
significant milestone in our journey towards better know-
ing and better managing diseases and towards better un-
derstanding how specific molecules, such as anaesthetics,
anti-neuropathic and neuromodulation techniques such
as Spinal Cord Stimulation affect the nervous system
among others. This is why we are launching this section,
Pain, Critical Care and Anaesthesia, “PCA”, of the Journal
of Translational Medicine in which we welcome multidis-
ciplinary contributions from colleagues interested in these
areas of expertise.
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